Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Option Care Health (OPCH) over the last 17 years, with Q3 2025 value amounting to -$16.7 million.

  • Option Care Health's Cash from Financing Activities rose 6251.57% to -$16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$273.2 million, marking a year-over-year decrease of 3617.45%. This contributed to the annual value of -$218.2 million for FY2024, which is 1769.72% up from last year.
  • According to the latest figures from Q3 2025, Option Care Health's Cash from Financing Activities is -$16.7 million, which was up 6251.57% from -$53.9 million recorded in Q2 2025.
  • In the past 5 years, Option Care Health's Cash from Financing Activities ranged from a high of $18.8 million in Q2 2022 and a low of -$107.3 million during Q1 2025
  • Moreover, its 5-year median value for Cash from Financing Activities was -$28.5 million (2024), whereas its average is -$38.0 million.
  • In the last 5 years, Option Care Health's Cash from Financing Activities soared by 73548.93% in 2022 and then plummeted by 806417.07% in 2023.
  • Quarter analysis of 5 years shows Option Care Health's Cash from Financing Activities stood at -$65.8 million in 2021, then skyrocketed by 98.31% to -$1.1 million in 2022, then tumbled by 6905.22% to -$77.8 million in 2023, then fell by 22.55% to -$95.4 million in 2024, then skyrocketed by 82.48% to -$16.7 million in 2025.
  • Its Cash from Financing Activities stands at -$16.7 million for Q3 2025, versus -$53.9 million for Q2 2025 and -$107.3 million for Q1 2025.